1 hr ago
Transcranial Pulse Stimulation for Alzheimer’s Now Available in India
A centre in Hyderabad is offering a treatment called Transcranial Pulse Stimulation, or TPS.
TPS sends short ultrasound pulses into selected parts of the brain.
Doctors use MRI-based guidance to help aim the pulses.
The treatment does not require surgery or electrodes placed inside the body.
Some early studies found possible improvements in certain thinking and daily-function measures.
However, researchers are still studying how useful TPS is for Alzheimer’s disease and other conditions.
Solaceum says patients will be assessed by specialists before treatment.
The centre recently invited doctors to learn about international experience with TPS.
More studies and long-term evidence are needed to understand its exact benefits.
Solaceum in Madhapur, Hyderabad, says it is India’s first and only centre offering Transcranial Pulse Stimulation as a clinical service.
TPS uses short ultrasound pulses and MRI-based neuronavigation to target specific brain regions without surgery or implanted electrodes.
Early research has reported encouraging findings in some cognitive and functional outcomes for Alzheimer’s disease and cognitive impairment.
Solaceum hosted a scientific session for Hyderabad neurologists and psychiatrists with international expert Prof. Dr. Ulrich Sprick.
The technology has European CE marking, but its role in Alzheimer’s and other neurological conditions remains under clinical evaluation.
- Who
- Solaceum, founded by consultant neurologist Dr. Sreekanth Vemula, is offering TPS; Prof. Dr. Ulrich Sprick presented international experience with the technology.
- What
- Transcranial Pulse Stimulation, a non-invasive ultrasound-based neuromodulation treatment, has been introduced as a clinical service in India.
- Where
- Solaceum, Madhapur, Hyderabad, Telangana, India.
- When
- The announcement was dated September 3; Solaceum recently hosted the related scientific session.
- Why
- The centre aims to provide Indian patients access to an emerging non-invasive technology while using specialist assessment, scientific evidence and patient selection.
Key facts
- Technology
- Transcranial Pulse Stimulation uses short ultrasound pulses to stimulate targeted brain areas.
- Navigation
- MRI-based neuronavigation is used to identify and target specific brain regions.
- Availability
- Solaceum says it is currently the first and only centre in India offering TPS clinically.
- Primary interest
- TPS is being explored for Alzheimer’s disease, cognitive impairment and other neurological conditions.
- Evidence status
- Early research has reported encouraging findings in certain cognitive and functional outcomes, but further studies are needed.
- European status
- The technology has received CE marking in Europe.
- Location
- Solaceum is located at Vijaya Diagnostic Centre, Hitech City Road, Madhapur, Hyderabad 500081.
Quotes
Dr. Sreekanth Vemula
Consultant neurologist, founder and chairman of Solaceum
“Alzheimer’s disease and dementia remain significant challenges for patients, families and clinicians. There is a growing need to explore innovative and non-invasive approaches that may complement existing neurological care. Technologies such as TPS are generating scientific interest because of their non-invasive nature and emerging clinical evidence.”
theprint.in
“At Solaceum, our objective is to make contemporary neuromodulation technologies accessible to Indian patients while ensuring that their use is guided by scientific evidence, specialist assessment and appropriate patient selection.”
theprint.in









